Laboratory Corporation of America Holdings company logo

# RNN 1st Gen Model Laboratory Corporation of America Holdings Medical laboratories

Prediction models:
Subscribe >> Deal exit on
Feb. 22, 2018
Deal entry on
Feb. 22, 2018
0.28%Expected margin
81.58% successful of 76 deals
$ 173.76 Last close price
at 21-feb-2018

LH

Model's trade recommendations 2.22% Return for period

14.54% Annual return

$17.75B Market Cap

β 0.93  

LH

Model (following trade recommendations)

LH

Underlying stock

S&P 500

Index
Return for period 2.22%
-0.62%
1.78%
52wk return 12.29%
24.99%
16.82%
52wk Range
137.51—178.11
2000.54—2399.63
Sortino ratio 2.83
Sharpe ratio 1.85
Norm. RMSE 0.58%
Downside risk 4.77%
Volatility 7.31%
  • STRONG BUY Analysts consensus recommendation

Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.

Industry sector: Medical

Sector classification: Medical laboratories

Deep Learning based analysis and prediction model for Laboratory Corporation of America Holdings (LH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for LH model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 101M
P/E 18.17
Shares Outstanding 102M
% Held by Insiders 0.90%
% Held by Institutions 90.41%
EPS (last reported FY) $9.60
EPS (last reported Q) $2.45
EPS, estimated (last reported Q) $2.37
Total revenues $10 B
Net income $1 B